Analysis of COVID-19 Impact: Tumor (Cancer) Profiling Market 2020-2024 | Increasing Cancer Research and Funding to Augment Growth | Technavio

Technavio has been monitoring the tumor (cancer) profiling market and it is poised to grow by USD 4.85 billion during 2020-2024, progressing at a CAGR of 10% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200629005559/en/

Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., QIAGEN NV, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Increasing cancer research and funding has been instrumental in driving the growth of the market.

Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.

Tumor (Cancer) Profiling Market 2020-2024: Segmentation

Tumor (Cancer) Profiling Market is segmented as below:

• Technology
  • Immunoassays
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • In-situ Hybridization
• Geographic Landscape
  • Asia
  • Europe
  • North America
  • ROW

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40128

Tumor (Cancer) Profiling Market 2020-2024: Scope

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The tumor (cancer) profiling market report covers the following areas:

• Tumor (Cancer) Profiling Market Size
• Tumor (Cancer) Profiling Market Trends
• Tumor (Cancer) Profiling Market Analysis

This study identifies the increasing adoption of personalized medicine as one of the prime reasons driving the tumor (cancer) profiling market growth during the next few years.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Tumor (Cancer) Profiling Market 2020-2024: Key Highlights

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will assist tumor (cancer) profiling market growth during the next five years
• Estimation of the tumor (cancer) profiling market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the tumor (cancer) profiling market
• Analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of tumor (cancer) profiling market vendors

Table of Contents:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value Chain Analysis

PART 04: MARKET SIZING

• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook

PART 05: FIVE FORCES ANALYSIS

• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

PART 06: MARKET SEGMENTATION BY TECHNOLOGY

• Market segmentation by technology
• Comparison by technology
• Immunoassays - Market size and forecast 2019-2024
• Next generation sequencing - Market size and forecast 2019-2024
• Polymerase chain reaction - Market size and forecast 2019-2024
• In-situ hybridization - Market size and forecast 2019-2024
• Market opportunity by technology

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

• Market drivers
• Market challenges

PART 11: MARKET TRENDS

• Increasing cancer research and funding
• Increasing adoption of personalized medicine
• Growing importance of genomics in therapeutics

PART 12: VENDOR LANDSCAPE

• Overview
• Landscape disruption
• Competitive scenario

PART 13: VENDOR ANALYSIS

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Agilent Technologies Inc.
• Becton, Dickinson and Co.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• QIAGEN NV
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

PART 14: APPENDIX

• Research methodology
• List of abbreviations
• Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200629005559/en/